| Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma | |
| Yao Xuesong; Yan Dong; Liu Dezhong; Zeng Huiying; Li Huai | |
| 2015 | |
| 卷号 | 3期号:4页码:929-935 |
| 关键词 | adverse events efficacy hepatocellular carcinoma sorafenib transcatheter arterial chemoembolization |
| ISSN号 | 2049-9450 |
| DOI | 10.3892/mco.2015.554 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6388840 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Yao Xuesong,Yan Dong,Liu Dezhong,et al. Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma[J],2015,3(4):929-935. |
| APA | Yao Xuesong,Yan Dong,Liu Dezhong,Zeng Huiying,&Li Huai.(2015).Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma.,3(4),929-935. |
| MLA | Yao Xuesong,et al."Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma".3.4(2015):929-935. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论